Pathophysiology, Differential Diagnosis, and Treatment of Diabetic Diarrhea

Dig Dis Sci. 2019 Dec;64(12):3385-3393. doi: 10.1007/s10620-019-05846-6.
No abstract available

Keywords: Diabetes; Diarrhea; Enteric nervous system; Motility.

Publication types

  • Review

MeSH terms

  • Antidiarrheals / therapeutic use
  • Autonomic Nervous System Diseases / etiology
  • Autonomic Nervous System Diseases / physiopathology*
  • Blind Loop Syndrome / diagnosis
  • Celiac Disease / diagnosis
  • Diabetes Mellitus, Type 1 / complications
  • Diabetes Mellitus, Type 1 / physiopathology*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / physiopathology*
  • Diabetic Neuropathies / etiology
  • Diabetic Neuropathies / physiopathology*
  • Diagnosis, Differential
  • Diarrhea / diagnosis
  • Diarrhea / drug therapy
  • Diarrhea / etiology
  • Diarrhea / physiopathology*
  • Diphenoxylate / therapeutic use
  • Enteric Nervous System / physiopathology*
  • Exocrine Pancreatic Insufficiency / diagnosis
  • Gastrointestinal Agents / therapeutic use
  • Gastrointestinal Motility / physiology
  • Hypoglycemic Agents / adverse effects
  • Imidazoles / therapeutic use
  • Inflammation
  • Inflammatory Bowel Diseases / diagnosis
  • Interstitial Cells of Cajal
  • Intestinal Absorption / physiology
  • Intestinal Mucosa
  • Irritable Bowel Syndrome / diagnosis
  • Loperamide / therapeutic use
  • Neuroglia
  • Non-Nutritive Sweeteners / adverse effects
  • Oxidative Stress / physiology
  • Phenylalanine / analogs & derivatives
  • Phenylalanine / therapeutic use
  • Serotonin 5-HT3 Receptor Antagonists / therapeutic use

Substances

  • Antidiarrheals
  • Gastrointestinal Agents
  • Hypoglycemic Agents
  • Imidazoles
  • Non-Nutritive Sweeteners
  • Serotonin 5-HT3 Receptor Antagonists
  • eluxadoline
  • Phenylalanine
  • Loperamide
  • Diphenoxylate